Pancreatic ductal adenocarcinoma: exploring clinicopathological trends and racial disparities in a comprehensive U.S. population-based study
-
Published:2024-04-14
Issue:
Volume:
Page:
-
ISSN:1699-3055
-
Container-title:Clinical and Translational Oncology
-
language:en
-
Short-container-title:Clin Transl Oncol
Author:
Yasinzai Abdul Qahar KhanORCID, Tareen Bisma, Tracy Katharine, Jamil Nimra, Khan Marjan, Ullah Hafeez, Raza Muhammad, Khan Amin Ullah, Arif Dauod, Waheed Abdul, Sidhwa Feroze, Misra Subhasis, Karki Nabin Raj, Karim Nagla Abdel, Cavalcante Ludimila, Ullah Asad
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Miller KD, Ortiz AP, Pinheiro PS, Bandi P, Minihan A, Fuchs HE, et al. Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J Clin. 2021;71(6):466–87. 2. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21. 3. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER cancer statistics review, 1975–2016, National Cancer Institute. Bethesda, MD. Based on November 2018 SEER data submission, posted to the SEER web site, April 2019. https://seer.cancer.gov/csr/1975_2016/. 4. Modolell I, Guarner L, Malagelada JR. Vagaries of clinical presentation of pancreatic and biliary tract cancer. Ann Oncol. 1999;10(Suppl 4):82–4. 5. McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846–61.
|
|